Skip to main content

Cognito Therapeutics

By Jessica Hagen | 03:34 pm | October 31, 2023
Cognito Therapeutics announced healthcare industry veteran Christian Howell joined its team as chief commercial officer.
By Jessica Hagen | 10:52 am | March 23, 2023
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
By Emily Olsen | 03:34 pm | August 26, 2021
Also: NeuroFlow teams up with the Independence Blue Cross Foundation and Trinity Health Mid-Atlantic to provide its mental health software to frontline healthcare workers.
By Dave Muoio | 03:25 pm | March 10, 2021
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.